<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36982312</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>09</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Saliva and Saliva Extracellular Vesicles for Biomarker Candidate Identification-Assay Development and Pilot Study in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5237</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24065237</ELocationID><Abstract><AbstractText>Saliva is gaining increasing attention as a source of biomarkers due to non-invasive and undemanding collection access. Extracellular vesicles (EVs) are nano-sized, cell-released particles that contain molecular information about their parent cells. In this study, we developed methods for saliva biomarker candidate identification using EV-isolation and proteomic evaluation. We used pooled saliva samples for assay development. EVs were isolated using membrane affinity-based methods followed by their characterization using nanoparticle tracking analysis and transmission electron microscopy. Subsequently, both saliva and saliva-EVs were successfully analyzed using proximity extension assay and label-free quantitative proteomics. Saliva-EVs had a higher purity than plasma-EVs, based on the expression of EV-proteins and albumin. The developed methods could be used for the analysis of individual saliva samples from amyotrophic lateral sclerosis (ALS) patients and controls (<i>n</i> = 10 each). The starting volume ranged from 2.1 to 4.9 mL and the amount of total isolated EV-proteins ranged from 5.1 to 42.6 &#xb5;g. Although no proteins were significantly differentially expressed between the two groups, there was a trend for a downregulation of ZNF428 in ALS-saliva-EVs and an upregulation of IGLL1 in ALS saliva. In conclusion, we have developed a robust workflow for saliva and saliva-EV analysis and demonstrated its technical feasibility for biomarker discovery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sjoqvist</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa 251-8555, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otake</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa 251-8555, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012463" MajorTopicYN="N">Saliva</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">extracellular vesicles</Keyword><Keyword MajorTopicYN="N">saliva</Keyword></KeywordList><CoiStatement>S.S. and K.O. are employees of Takeda Pharmaceutical Company Limited. S.S. is co-founder and co-owner of ExTherea Limited. S.S. is a minor shareholder of Takeda Pharmaceutical Company Limited and Olink Proteomics AB. K.O. is a minor shareholder of Takeda Pharmaceutical Company Limited.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36982312</ArticleId><ArticleId IdType="pmc">PMC10049503</ArticleId><ArticleId IdType="doi">10.3390/ijms24065237</ArticleId><ArticleId IdType="pii">ijms24065237</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yoshizawa J.M., Schafer C.A., Schafer J.J., Farrell J.J., Paster B.J., Wong D.T.W. Salivary biomarkers: Toward future clinical and diagnostic utilities. Clin. Microbiol. Rev. 2013;26:781&#x2013;791. doi: 10.1128/CMR.00021-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00021-13</ArticleId><ArticleId IdType="pmc">PMC3811231</ArticleId><ArticleId IdType="pubmed">24092855</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler-Laporte G., Lawandi A., Schiller I., Yao M.C., Dendukuri N., McDonald E.G., Lee T.C. Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis. JAMA Intern. Med. 2021;181:353&#x2013;360. doi: 10.1001/jamainternmed.2020.8876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.8876</ArticleId><ArticleId IdType="pmc">PMC7811189</ArticleId><ArticleId IdType="pubmed">33449069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa S., Sugimoto M., Kitabatake K., Sugano A., Nakamura M., Kaneko M., Ota S., Hiwatari K., Enomoto A., Soga T., et al. Identification of salivary metabolomic biomarkers for oral cancer screening. Sci. Rep. 2016;6:31520. doi: 10.1038/srep31520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31520</ArticleId><ArticleId IdType="pmc">PMC4990923</ArticleId><ArticleId IdType="pubmed">27539254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney J., Morelli T., Braun T., Ramseier C., Herr A., Sugai J., Shelburne C., Rayburn L., Singh A., Giannobile W. Saliva/pathogen biomarker signatures and periodontal disease progression. J. Dent. Res. 2011;90:752&#x2013;758. doi: 10.1177/0022034511399908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034511399908</ArticleId><ArticleId IdType="pmc">PMC3144122</ArticleId><ArticleId IdType="pubmed">21406610</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt C., Bien C.G., Helmer R., May T.W. Assessment of the correlations of lacosamide concentrations in saliva and serum in patients with epilepsy. Epilepsia. 2018;59:e34&#x2013;e39. doi: 10.1111/epi.14023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.14023</ArticleId><ArticleId IdType="pubmed">29450894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton N.J., Ide M., Zetterberg H., Blennow K. Salivary Biomarkers for Alzheimer&#x2019;s Disease and Related Disorders. Neurol Ther. 2019;8:83&#x2013;94. doi: 10.1007/s40120-019-00168-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-019-00168-1</ArticleId><ArticleId IdType="pmc">PMC6908535</ArticleId><ArticleId IdType="pubmed">31833026</ArticleId></ArticleIdList></Reference><Reference><Citation>Noorbakhsh-Sabet N., Zand R., Zhang Y., Abedi V. Artificial Intelligence Transforms the Future of Health Care. Am. J. Med. 2019;132:795&#x2013;801. doi: 10.1016/j.amjmed.2019.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2019.01.017</ArticleId><ArticleId IdType="pmc">PMC6669105</ArticleId><ArticleId IdType="pubmed">30710543</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Shi W. Salivary biomarkers for caries risk assessment. J. Calif. Dent. Assoc. 2013;41:107&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3825179</ArticleId><ArticleId IdType="pubmed">23505756</ArticleId></ArticleIdList></Reference><Reference><Citation>Arakaki R., Ushio A., Otsuka K., Kudo Y., Ishimaru N. A novel method for measuring small amounts of saliva in mice. Oral Sci. Int. 2019;16:178&#x2013;180. doi: 10.1002/osi2.1013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/osi2.1013</ArticleId></ArticleIdList></Reference><Reference><Citation>Willms E., Caba&#xf1;as C., M&#xe4;ger I., Wood M.J.A., Vader P. Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression. Front. Immunol. 2018;9:738. doi: 10.3389/fimmu.2018.00738.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00738</ArticleId><ArticleId IdType="pmc">PMC5936763</ArticleId><ArticleId IdType="pubmed">29760691</ArticleId></ArticleIdList></Reference><Reference><Citation>El Andaloussi S., M&#xe4;ger I., Breakefield X.O., Wood M.J.A. Extracellular vesicles: Biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 2013;12:347&#x2013;357. doi: 10.1038/nrd3978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3978</ArticleId><ArticleId IdType="pubmed">23584393</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun I.O., Lerman L.O. Urinary Extracellular Vesicles as Biomarkers of Kidney Disease: From Diagnostics to Therapeutics. Diagnostics. 2020;10:311. doi: 10.3390/diagnostics10050311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics10050311</ArticleId><ArticleId IdType="pmc">PMC7277956</ArticleId><ArticleId IdType="pubmed">32429335</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl E.J., Abner E.L., Jicha G.A., Kapogiannis D., Schwartz J.B. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer&#x2019;s disease. FASEB J. 2018;32:888&#x2013;893. doi: 10.1096/fj.201700731R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700731R</ArticleId><ArticleId IdType="pmc">PMC5888398</ArticleId><ArticleId IdType="pubmed">29025866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjoqvist S., Otake K., Hirozane Y. Analysis of cerebrospinal fluid extracellular vesicles by proximity extension assay: A comparative study of four isolation kits. Int. J. Mol. Sci. 2020;21:9425. doi: 10.3390/ijms21249425.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249425</ArticleId><ArticleId IdType="pmc">PMC7763352</ArticleId><ArticleId IdType="pubmed">33321992</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojtech L., Zhang M., Dav&#xe9; V., Levy C., Hughes S.M., Wang R., Calienes F., Prlic M., Nance E., Hladik F. Extracellular vesicles in human semen modulate antigen-presenting cell function and decrease downstream antiviral T cell responses. PLoS ONE. 2019;14:e0223901. doi: 10.1371/journal.pone.0223901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0223901</ArticleId><ArticleId IdType="pmc">PMC6797208</ArticleId><ArticleId IdType="pubmed">31622420</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Xia Z., Shang Z., Sun K., Niu X., Qian L., Fan L.-Y., Cao C.-X., Xiao H. Facile preparation of salivary extracellular vesicles for cancer proteomics. Sci. Rep. 2016;6:24669. doi: 10.1038/srep24669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24669</ArticleId><ArticleId IdType="pmc">PMC4835767</ArticleId><ArticleId IdType="pubmed">27091080</ArticleId></ArticleIdList></Reference><Reference><Citation>Gai C., Camussi F., Broccoletti R., Gambino A., Cabras M., Molinaro L., Carossa S., Camussi G., Arduino P.G. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma. BMC Cancer. 2018;18:439. doi: 10.1186/s12885-018-4364-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-018-4364-z</ArticleId><ArticleId IdType="pmc">PMC5907383</ArticleId><ArticleId IdType="pubmed">29669525</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai K., Minamisawa T., Suga K., Yajima Y., Shiba K. Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations. J. Extracell. Vesicles. 2016;5:30829. doi: 10.3402/jev.v5.30829.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v5.30829</ArticleId><ArticleId IdType="pmc">PMC4871899</ArticleId><ArticleId IdType="pubmed">27193612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W., Li S., Zhang G., Xu H.H.K., Zhang K., Bai Y. New frontiers of oral sciences: Focus on the source and biomedical application of extracellular vesicles. Front. Bioeng. Biotechnol. 2022;10:1023700. doi: 10.3389/fbioe.2022.1023700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2022.1023700</ArticleId><ArticleId IdType="pmc">PMC9627311</ArticleId><ArticleId IdType="pubmed">36338125</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Lin Y., Luo Y., Xiong X., Wang L., Durante K., Li J., Zhou F., Guo Y., Chen S., et al. A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: A multicenter prospective study. Mol. Cancer. 2022;21:21. doi: 10.1186/s12943-022-01499-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-022-01499-8</ArticleId><ArticleId IdType="pmc">PMC8764835</ArticleId><ArticleId IdType="pubmed">35042519</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C., Witwer K.W., Aikawa E., Alcaraz M.J., Anderson J.D., Andriantsitohaina R., Antoniou A., Arab T., Archer F., Atkin-Smith G.K., et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 2018;7:1535750. doi: 10.1080/20013078.2018.1535750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ill&#xe1;n-Gala I., Alcolea D., Montal V., Dols-Icardo O., Mu&#xf1;oz L., de Luna N., Tur&#xf3;n-Sans J., Cort&#xe9;s-Vicente E., S&#xe1;nchez-Saudin&#xf3;s M.B., Subirana A., et al. CSF sAPP&#x3b2;, YKL-40, and NfL along the ALS-FTD spectrum. Neurology. 2018;91:e1619&#x2013;e1628. doi: 10.1212/WNL.0000000000006383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006383</ArticleId><ArticleId IdType="pubmed">30291183</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson A.G., Gray E., Th&#xe9;z&#xe9;nas M.-L., Charles P.D., Evetts S., Hu M.T., Talbot K., Fischer R., Kessler B.M., Turner M.R. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis. Ann. Neurol. 2018;83:258&#x2013;268. doi: 10.1002/ana.25143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25143</ArticleId><ArticleId IdType="pubmed">29331073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhle J., Lindberg R.L.P., Regeniter A., Mehling M., Steck A.J., Kappos L., Czaplinski A. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur. J. Neurol. 2009;16:771&#x2013;774. doi: 10.1111/j.1468-1331.2009.02560.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02560.x</ArticleId><ArticleId IdType="pubmed">19236470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjoqvist S., Otake K. A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates. Biochem. Biophys. Res. Commun. 2022;613:166&#x2013;173. doi: 10.1016/j.bbrc.2022.04.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2022.04.127</ArticleId><ArticleId IdType="pubmed">35567903</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson R.J., Kalra H., Mathivanan S. ExoCarta as a resource for exosomal research. J. Extracell. Vesicles. 2012;1:18374. doi: 10.3402/jev.v1i0.18374.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v1i0.18374</ArticleId><ArticleId IdType="pmc">PMC3760644</ArticleId><ArticleId IdType="pubmed">24009883</ArticleId></ArticleIdList></Reference><Reference><Citation>Veerman R.E., Teeuwen L., Czarnewski P., Akpinar G.G., Sandberg A., Cao X., Pernemalm M., Orre L.M., Gabrielsson S., Eldh M. Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin. J. Extracell. Vesicles. 2021;10:e12128. doi: 10.1002/jev2.12128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12128</ArticleId><ArticleId IdType="pmc">PMC8298890</ArticleId><ArticleId IdType="pubmed">34322205</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;rgens A., Corso G., Hagey D.W., Wiklander R.J., Gustafsson M.O., Felldin U., Lee Y., Bostancioglu R.B., Sork H., Liang X., et al. Identification of storage conditions stabilizing extracellular vesicles preparations. J. Extracell. Vesicles. 2022;11:e12238. doi: 10.1002/jev2.12238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12238</ArticleId><ArticleId IdType="pmc">PMC9206228</ArticleId><ArticleId IdType="pubmed">35716060</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Lyon D., Junge A., Wyder S., Huerta-Cepas J., Simonovic M., Doncheva N.T., Morris J.H., Bork P., et al. STRING v11: Protein&#x2013;protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607&#x2013;D613. doi: 10.1093/nar/gky1131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1131</ArticleId><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Nastou K.C., Lyon D., Kirsch R., Pyysalo S., Doncheva N.T., Legeay M., Fang T., Bork P., et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605&#x2013;D612. doi: 10.1093/nar/gkaa1074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl&#xe9;n M., Fagerberg L., Hallstr&#xf6;m B.M., Lindskog C., Oksvold P., Mardinoglu A., Sivertsson &#xc5;., Kampf C., Sj&#xf6;stedt E., Asplund A., et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419. doi: 10.1126/science.1260419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1260419</ArticleId><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Willforss J., Chawade A., Levander F. NormalyzerDE: Online Tool for Improved Normalization of Omics Expression Data and High-Sensitivity Differential Expression Analysis. J. Proteome Res. 2019;18:732&#x2013;740. doi: 10.1021/acs.jproteome.8b00523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00523</ArticleId><ArticleId IdType="pubmed">30277078</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyanova S., Temu T., Sinitcyn P., Carlson A., Hein M.Y., Geiger T., Mann M., Cox J. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods. 2016;13:731&#x2013;740. doi: 10.1038/nmeth.3901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3901</ArticleId><ArticleId IdType="pubmed">27348712</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>